德国财政部长：德国AAA评级未受威胁。

Shanghai Composite +0.46%, Shenzhen Composite +1.32%, ChiNext +3.11%, STAR 50 +2.8% at close after indices stabilized and rallied into the afternoon. Turnover on Shanghai and Shenzhen exceeded 1.6 trillion yuan; more than 3,500 stocks advanced. CPO-themed stocks led gains, with Yuanjie Technology and Zhishang Technology hitting daily limits; InnoLight, Taichen Guang and Zhongji Xuchuang rose over 15%, and Tianfu Communication, Liante Technology and Changhua Guangxin gained more than 10%. PCB names extended recent strength—Dongshan Precision, Guangyang and Bojie hit limits; JPT jumped about 14%, Nanya New Material up ~12%. AI compute chip names outperformed: Guangku Technology +11%, with Tianpu, Xingsen Technology and Cambricon also higher. Baijiu sector underperformed broadly; Huangtai fell over 5%, while Fenjiu, Luzhou Laojiao, Wuliangye and Kweichow Moutai declined.

At its Q3 2026 results briefing, Botuo Biotech said it will retain POCT rapid diagnostics as its core business, expand its product matrix, accelerate domestic and overseas registrations/certifications, and advance a microfluidic fluorescent detection platform and high-end microfluidic chip reagent development to strengthen POCT competitiveness. The company said it is also deploying an industrial investment platform—via equity stakes, M&A and participation in industry funds—to explore frontier medical areas including brain–computer interfaces (BCI) and AI-driven healthcare, aiming to open long-term potential growth avenues.